Skip to main content
Equibles

EDMOND DE ROTHSCHILD HOLDING S.A.

Position in DNLI — Denali Therapeutics Inc.

CIK 1649647 Chambesy, V8
Back to DNLI Full portfolio

Position in DNLI

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$4,245,857
-$87,199 QoQ
Shares Held
165,080
-26.9% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#71
of 294 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

EDMOND DE ROTHSCHILD HOLDING S.A. holds $84,636,966 across 13 Biotechnology names. DNLI ranks #6 (5.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BMRN
Biomarin Pharmaceutical Inc
 687,030 $39,311,856
2 ONC
BeOne Medicines Ltd.
 33,660 $9,592,090
3 IONS
Ionis Pharmaceuticals Inc
 113,320 $8,985,142
4 BNTX
BioNTech SE
 92,310 $8,589,445
5 MRNA
Moderna, Inc.
 70,747 $4,954,411
6 DNLI
Denali Therapeutics Inc.
This page 		165,080 $4,245,857
7 GERN
Geron Corp
 2,330,000 $2,982,400
8 NRIX
Nurix Therapeutics, Inc.
 90,000 $2,183,400

All Filings in DNLI

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,245,857 165,080
2026-03-31 $4,333,056 225,680
2025-12-31 $3,725,976 225,680
2025-09-30 $2,986,473 205,680
2025-06-30 $2,877,463 205,680
2025-03-31 $2,796,219 205,680
2024-12-31 $4,191,758 205,680
2024-09-30 $5,991,458 205,680
2024-06-30 $4,775,889 205,680
2024-03-31 $4,220,553 205,680
2023-12-31 $3,555,492 165,680
2023-09-30 $2,060,524 99,880
2023-06-30 $2,947,458 99,880
2023-03-31 $2,301,235 99,880
2022-12-31 $2,777,662 99,880
2022-09-30 $3,065,317 99,880
2022-06-30 $2,939,468 99,880
2022-03-31 $3,213,139 99,880
2021-12-31 $4,454,648 99,880
2021-09-30 $5,045,000 100,000
2021-06-30 $6,055,568 77,200
2021-03-31 $3,254,700 57,000
2020-12-31 $1,256,400 15,000